Christine M. Ardito, Ph.D.
Affiliations: | 2011 | Molecular and Cellular Pharmacology | Stony Brook University, Stony Brook, NY, United States |
Area:
Cell Biology, Oncology, Molecular BiologyGoogle:
"Christine Ardito"Parents
Sign in to add mentor| Howard C. Crawford | grad student | 2011 | SUNY Stony Brook | |
| (ADAM10 and ADAM17 regulate stages of pancreatic disease by aberrant activation of Notch and EGFR signaling pathways.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ardito CM, Grüner BM, Takeuchi KK, et al. (2012) EGF receptor is required for KRAS-induced pancreatic tumorigenesis. Cancer Cell. 22: 304-17 |
| Halbrook CJ, Takeuchi KK, Ardito CM, et al. (2012) Abstract B84: EGFR activation by the ADAM17 sheddase is required for Kras-induced pancreatic tumorigenesis. Cancer Research. 72 |
| Grüner B, Ardito C, Lubeseder-Martellato C, et al. (2012) EGF Rezeptor signaling ist obligatorisch für die Kras-induzierte Entwicklung des Pankreaskarzinoms Zeitschrift FüR Gastroenterologie. 50 |
| Ardito CM, Briggs CD, Crawford HC. (2008) Targeting of extracellular proteases required for the progression of pancreatic cancer. Expert Opinion On Therapeutic Targets. 12: 605-19 |